Global Renal Denervation Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027
"Global Renal Denervation Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2027” is a recent report generated by MarketResearch.biz, which offers in-depth insights, revenue details, and other vital information regarding the global renal denervation market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global renal denervation market report has been segmented on the basis of technology, and region.
Renal denervation is also known as renal sympathetic denervation. Renal denervation is a type of minimally invasive procedure which involves endovascular access from femoral artery using catheter-mounted device into the renal artery. The device uses radiofrequency ablation or ultrasound ablation for the treatment of resistant high blood pressure which is unable to control by medication. Renal denervation reduces sympathetic efferent activity to the kidney and thus reducing the blood pressure.
Rising prevalence of serious health conditions such as hypertension or high blood pressure, is a key factor expected to drive growth of the global renal denervationmarket over the forecast period. Short procedure time and prolong effect of renal denervation procedure, is another factor anticipated to propel growth of the target market over the forecast period. In addition, rapidly changing lifestyle of individuals and developing healthcare infrastructure in emerging economies, are other factors expected to fuel growth of the target market over the forecast period. Moreover, rising geriatric coupled with emergence of better renal denervation (RDN) devices is expected to further bolster growth of the target market over the forecast period.
However, high cost of renal denervation devices and procedure, is a major factor expected to restrain revenue growth of renal denervation market over the forecast period. In addition, lower awareness of RDN devices as compared to traditional drug-based therapy, is another factor expected to hinder growth of the target market during the forecast period.
Increasing innovations and R&D investments for renal sympathetic denervation, is expected to create a lucrative opportunity for driving growth of the global renal denervation market over the forecast period.
Analysis by Segment:
On the basis of application, the radiofrequency based segment is accounted for major share in terms of revenue and volume in the target market in the next coming years. This can be attributed to the advantages of radiofrequency therapies such as prolong effect, short treatment time, and higher safety. The ultrasound based segment is projected to witness highest growth rate in the global renal denervation market over the forecast period, owing to its advantages as compared to radiofrequency based systems.
Analysis by Region:
The market in North America is accounted for major revenue share in the global renal denervation market and is expected to maintain its dominance over the forecast period, owing to increasing research and development activities for the development of efficient devices in countries in the region. The Europe renal denervation market also registered significant growth rate to the global renal denervation market over the forecast period. The renal denervation market in the Asia Pacific is expected to grow at a moderate rate in terms of revenue over the forecast period owing to increasing prevalence of life–style related disorders such as diabetes and obesity in countries in the region. Increasing number of drug-resistant hypertension cases, is also expected to support revenue growth of renal denervation market.
Segmentation on The Basis of Technology:
- Radiofrequency based
- Ultrasound based
- Cryoablation based
- Micro-Infusion based
- Medtronic plc
- Cardiosonic, Inc.
- Kona Medical, Inc.
- Abbott Laboratories
- Ablative Solutions, Inc.
- Renal Dynamics, LLC
- Mercator MedSystems, Inc.
- ReCor Medical, Inc.
- Boston Scientific Corporation
- Symple Surgical, Inc.
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!